Spliceosome mutations: 1 plus 1 does not always equal 2
In this issue of Blood, Taylor et al show that 2 splicing factor mutations can coexist in the same cell in myeloid malignancy patients when their combination includes less common mutant alleles.
Main Authors: | Pellagatti, A, Boultwood, J |
---|---|
Format: | Journal article |
Language: | English |
Published: |
American Society of Hematology
2020
|
Similar Items
-
The impact of spliceosome mutations in MDS
by: Jacqueline Boultwood, et al.
Published: (2019-06-01) -
Does one plus one always equal two? Structural differences between nesfatin-1, -2, and nesfatin-1/2
by: Rafał Lenda, et al.
Published: (2022-10-01) -
Commentary: One plus one does not always equal two: Mitochondrial cardioprotectionCentral Message
by: Alvise Guariento, MD, et al.
Published: (2021-12-01) -
Impact of spliceosome mutations on RNA splicing in myelodysplasia: dysregulated genes/pathways and clinical associations
by: Pellagatti, A, et al.
Published: (2018) -
An investigation of the role of mutations in the spliceosome machinery in the myelodysplastic syndromes
by: Lee, J
Published: (2022)